Page last updated: 2024-09-05

anidulafungin and amprenavir

anidulafungin has been researched along with amprenavir in 1 studies

Compound Research Comparison

Studies
(anidulafungin)
Trials
(anidulafungin)
Recent Studies (post-2010)
(anidulafungin)
Studies
(amprenavir)
Trials
(amprenavir)
Recent Studies (post-2010) (amprenavir)
568333315559194

Protein Interaction Comparison

ProteinTaxonomyanidulafungin (IC50)amprenavir (IC50)
Gag-Pol polyproteinHuman immunodeficiency virus type 1 (BRU ISOLATE)0.027
Gag-Pol polyproteinHuman immunodeficiency virus type 2 (ISOLATE ROD)0.0026
Gag polyproteinHIV-1 M:B_MN0.013
Cytochrome P450 3A4Homo sapiens (human)1
Gag-Pol polyproteinHuman immunodeficiency virus type 1 (NEW YORK-5 ISOLATE)0.0558
Thromboxane-A synthase Homo sapiens (human)6.727
Protease Human immunodeficiency virus 10.1553

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for anidulafungin and amprenavir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016